Boerner Christopher S. insider trades
Boerner Christopher S. has filed 18 Form 4s with the SEC that we hold, for Bristol Myers Squibb Co (BMY) (Chief Executive Officer, Director) and Colgate Palmolive Co (CL) (Director). Across all of them we count 3 purchases worth $359.7K and 1 sale worth $2.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 29,532 shares of Bristol Myers Squibb Co worth $2.0M, dated 2022-03-14. The first filing on our record is dated 2021-12-06 and the latest 2026-05-13.
Bristol Myers Squibb Co (BMY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-14 | S, sale reported on Form 4 | 29,532 | $2.0M | 2022-03-16 |
| 2023-11-28 | P, purchase reported on Form 4 | 3,071 | $150.0K | 2023-11-30 |
| 2023-12-05 | P, purchase reported on Form 4 | 2,000 | $99.6K | 2023-12-07 |
| 2025-02-20 | P, purchase reported on Form 4 | 2,000 | $110.1K | 2025-02-21 |
Colgate Palmolive Co (CL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1543747) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms